Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-COVID rebound in invasive pneumococcal disease driven by resurgence of serotype 4 among American Indian individuals in the Southwest United States.

The Journal of infectious diseases·2026
Same author

COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024.

BMJ global health·2026
Same author

Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites.

Vaccines·2026
Same author

Factors associated with exclusive breastfeeding at 6 months postpartum: a prospective mixed-method cohort study.

Pediatric research·2026
Same author

Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investment.

Vaccine·2025
Same author

Causes and risk factors for deaths in young infants in South Asia: the ANISA prospective population-based observational cohort study.

BMJ global health·2025

Related Experiment Video

Updated: Jul 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Implementing rotavirus vaccination in Asia.

Mathuram Santosham1, E Anthony S Nelson, Joseph S Bresee

  • 1Department of International Health, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, E8132, 621 N. Washington Street, Baltimore, MD 21205, USA. msantosh@jhsph.edu

Vaccine
|September 21, 2007
PubMed
Summary

Rotavirus vaccines are recommended for national immunization programs in Asia. Further data on disease burden and economic impact are needed for widespread implementation to reduce childhood illness.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Experiment Videos

Last Updated: Jul 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Rotavirus is a significant cause of childhood morbidity and mortality in Asia.
  • The Asian Pacific Pediatric Association (APPA) and international experts convened to discuss rotavirus vaccine implementation.
  • Existing rotavirus vaccines are safe, well-tolerated, and efficacious, with more candidates in development.

Purpose of the Study:

  • To summarize recommendations for rotavirus vaccine integration into National Immunization Programmes (NIP) in Asian countries.
  • To highlight the need for additional disease burden and economic evaluation data for policy decisions.
  • To address implementation considerations, including co-administration with other vaccines.

Main Methods:

  • Expert consensus and discussion during the 2006 APPA meeting.
  • Review of existing rotavirus vaccine data (safety, efficacy).
  • Consideration of disease burden and economic evaluation requirements.

Main Results:

  • Strong recommendation for rotavirus vaccine use in Asian NIPs.
  • Agreement on the necessity of further disease burden data and economic evaluations for nationwide implementation.
  • Discussion of practical aspects like concomitant vaccine use.

Conclusions:

  • Rotavirus vaccines offer substantial potential to decrease rotavirus disease burden in Asian children.
  • Policy decisions on vaccine introduction require robust data and economic assessments.
  • Strategic implementation planning is crucial for maximizing vaccine impact on child health in Asia.